Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

148 results about "Biomedical implant" patented technology

Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof

The use of collagen as a biomedical implant raises safety issues towards viruses and prions. The physicochemical changes and the in vitro and in vivo biocompatibility of collagen treated with heat, and by formic acid (FA), trifluoroacetic acid (TFA), tetrafluoroethanol (TFE) and hexafluoroiso-propanol (HFIP) were investigated. FA and TFA resulted in extensive depurination of nucleic acids while HFIP and TFE did so to a lesser degree. The molecules of FA, and most importantly of TFA, remained within collagen. Although these two acids induced modification in the secondary structure of collagen, resistance to collagenase was not affected and, in vitro, cell growth was not impaired. Severe dehydrothermal treatment, for example 110° C. for 1-3 days under high vacuum, also succeeded in removing completely nucleic acids. Since this treatment also leads to slight cross-linking, it could be advantageously used to eliminate prion and to stabilize gelatin products. Finally, prolonged treatment with TFA provides a transparent collagen, which transparency is further enhanced by adding glycosaminoglycans or proteoglycans, particularly hyaluronic acid. All the above treatments could offer a safe and biocompatible collagen-derived material for diverse biomedical uses, by providing a virus or prion-free product.
Owner:UNIV LAVAL

Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering

A novel BC fermentation technique for controlling 3D shape, thickness and architecture of the entangled cellulose nano-fibril network is presented. The resultant nano-cellulose based structures are useful as biomedical implants and devices, are useful for tissue engineering and regenerative medicine, and for health care products. More particularly, embodiments of the present invention relate to systems and methods for the production and control of 3-D architecture and morphology of nano-cellulose biomaterials produced by bacteria using any biofabrication process, including the novel 3-D Bioprinting processes disclosed. Representative processes according to the invention involve control of the rate of production of biomaterial by bacteria achieved by meticulous control of the addition of fermentation media using a microfluidic system. In exemplary embodiments, the bacteria gradually grew up along the printed alginate structure that had been placed into the culture, incorporating it. After culture, the printed alginate structure was successfully removed revealing porosity where the alginate had been placed. Porosity and interconnectivity of pores in the resultant 3-D architecture can be achieved by porogen introduction using, e.g., ink-jet printer technology.
Owner:VIRGINIA TECH INTPROP INC

Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering

A novel BC fermentation technique for controlling 3D shape, thickness and architecture of the entangled cellulose nano-fibril network is presented. The resultant nano-cellulose based structures are useful as biomedical implants and devices, are useful for tissue engineering and regenerative medicine, and for health care products. More particularly, embodiments of the present invention relate to systems and methods for the production and control of 3-D architecture and morphology of nano-cellulose biomaterials produced by bacteria using any biofabrication process, including the novel 3-D Bioprinting processes disclosed. Representative processes according to the invention involve control of the rate of production of biomaterial by bacteria achieved by meticulous control of the addition of fermentation media using a microfluidic system. In exemplary embodiments, the bacteria gradually grew up along the printed alginate structure that had been placed into the culture, incorporating it. After culture, the printed alginate structure was successfully removed revealing porosity where the alginate had been placed. Porosity and interconnectivity of pores in the resultant 3-D architecture can be achieved by porogen introduction using, e.g., ink-jet printer technology.
Owner:VIRGINIA TECH INTPROP INC

Zn-Li series zinc alloy as well as preparation method and application thereof

The invention discloses a Zn-Li series zinc alloy as well as a preparation method and application thereof. The Zn-Li series zinc alloy comprises Zn and Li; and based on weight percent, the mass percent content of the Li in the zinc alloy accounts for 0 to 30%, but not including 0. The preparation method of the Zn-Li series zinc alloy comprises the following steps: (1) mixing the Zn and the Li to obtain a mixture; (2) treating the mixture according to the following step a) or step b) and then cooling the mixture to obtain the zinc alloy: a) under the protection of a CO2 and SF6 atmosphere, carrying out smelting or sintering on the mixture; and b) under the protection of a vacuum atmosphere, dissolving hydrogen gas into the mixture and carrying out the smelting. The zinc alloy prepared by the preparation method disclosed by the invention has an excellent mechanical property and can provide a long-term effective supporting force in vivo; and the zinc alloy has excellent cellular compatibility, blood compatibility and tissue and organ compatibility and can be used for preparing biomedical implant materials.
Owner:PEKING UNIV +1

Medical degradable and absorbable Mg-Sr-Ca series magnesium alloy implant and preparation method thereof

The invention relates to a medical degradable and absorbable Mg-Sr-Ca series magnesium alloy implant and a preparation method thereof. The medical implant is made of a Mg-Sr-Ca series alloy, wherein strontium is 0 to 5 percent (but not 0) of the weight of the Mg-Sr-Ca series alloy; calcium is 0 to 2 percent (but not 0) of the weight of the Mg-Sr-Ca series alloy; a small amount of one or more of trace elements, namely manganese, zirconium, tin, rare earth and yttrium may be contained, and are not more than 2 percent of weight of the Mg-Sr-Ca series alloy; and the balance is magnesium. In-vivo and in-vitro tests prove that the Mg-Sr-Ca series alloy implant is nontoxic, has high histocompatibility, and is a reliable biomedical implant material.
Owner:浙江海圣医疗器械股份有限公司

Medical implanted titanium alloy with low elastic modulus and high fatigue strength and preparation method

The invention relates to a medical implanted titanium alloy with low elastic modulus and high fatigue strength and a preparation method. The medical implanted titanium alloy comprises, by weight, 30-33% of Nb, 1-6% of Zr, 2-4% of Mo, 0.20-0.40% of O, and the balance Ti. The preparation method of the medical implanted titanium alloy specifically comprises the steps that smelting is conducted by using a vacuum non-consumable electric-arc furnace to obtain an alloy ingot with uniform ingredients, solution treatment is conducted at 850-950 DEG C after the alloy ingot is subjected to hot forging into bar materials, and water cooling is conducted to the room temperature; then cold rolling deformation processing is conducted, and the deformation quantity is 80-90%; and finally, aging heat treatment is conducted, the heating temperature of the aging heat treatment is 400-500 DEG C, and the heat preservation time is 1-12 h. According to the medical implanted titanium alloy with the low elasticmodulus and the high fatigue strength and the preparation method, after cold rolling and heat treatment, the strength is significantly higher than that of a current most-widely-applied medical implanted titanium alloy Ti-6Al-4V, the fatigue strength is comparable to Ti-6Al-4V, the elastic modulus is only 52% of Ti-6Al-4V, the biocompatibility and the mechanical compatibility are more excellent, and the medical implanted titanium alloy can be applied to preparation of biomedical implants.
Owner:SOUTHEAST UNIV

Ti, Al and Nb alloys

InactiveUS20070084530A1Large applied stressImprove mechanical propertiesProsthesisMammalProsthesis
Ti(x %)Al(y %)Nb alloys as implants for biomedical implant apparatus, where x is between about 45 and 54% by atoms, y is between about 15 to 25% by atoms are described. The implants are useful for prosthesis implanted into the body of a human, or lower mammals and in various structures.
Owner:BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products